Medi Caps Ratios

Medi Caps Ltd Ratios

The Medi Caps Ltd Ratios page provides a complete fundamental analysis of Medi Caps Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Medi Caps Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Medi Caps Ltd (NSE: MEDICAPS, BSE: 523144) is currently trading at ₹21.85, with a market capitalization of ₹280.82M. As a major player in the Health technology sector and Pharmaceuticals: major industry, Medi Caps Ltd remains a key stock for fundamental analysis using Medi Caps Ltd Ratios.

Medi Caps Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Medi Caps Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Medi Caps Ltd Ratios.

Historically, the Medi Caps Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 24.81
• 2021: 6.14
• 2020: 4.52

The decline in Medi Caps Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Medi Caps Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.43.

Historical P/B trend:

• 2024: 0.43
• 2023: 0.46
• 2022: 0.37
• 2021: 0.53

Medi Caps Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Medi Caps Ltd P/S ratio currently stands at 2.04, an important part of Medi Caps Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 2.04
• 2023: 2.03
• 2022: 0.88
• 2021: 0.91

The rising Medi Caps Ltd P/S ratio indicates improved revenue valuation by investors.

Medi Caps Ltd Price to Cash Flow Ratio (P/CF)

The Medi Caps Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 10.20.

Historical Medi Caps Ltd Price to Cash Flow Ratio:

• 2024: 10.20
• 2023: 7.96
• 2022: 0
• 2021: 8.82
• 2020: 3.28

The rising Medi Caps Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Medi Caps Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Medi Caps Ltd EV currently stands at ₹175.54M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 175.54M
• 2023: 196.52M
• 2022: 73.15M
• 2021: 252.02M

Medi Caps Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Medi Caps Ltd EV/EBITDA ratio is currently 0, a key metric in Medi Caps Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 1.37
• 2021: 2.91

Stable Medi Caps Ltd EV/EBITDA indicates balanced valuation.

Medi Caps Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Medi Caps Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Medi Caps Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Medi Caps Ltd ROE currently stands at -0.47%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -0.47
• 2023: -1.87
• 2022: 1.59
• 2021: 9.09

Declining ROE indicates pressure on profitability.

Medi Caps Ltd Ratios Analysis Summary

The Medi Caps Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Medi Caps Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Medi Caps Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.